News

Posted on October 14, 2017

Nippon Chemiphar and SOM Biotech to Cooperate on New, Orphan Disease Indications for bevantolol (Calvan®)

Posted on September 26, 2017

SOM Biotech at 2017 ASEBIO Investor Day

Posted on September 18, 2017

SOM Biotech invited at Chinese-Swiss Health Collaborations Forum

Posted on September 4, 2017

II Workshop sobre Transferencia del Conocimiento Científico en la Distrofia Muscular de Duchenne

Posted on July 25, 2017

SOM Biotech licenses its first product and expands to the United States

Posted on July 17, 2017

SOM Biotech at the 2017 New York Venture Summit

Posted on July 11, 2017

21st Summer School of the University of Barcelona

Posted on July 5, 2017

9th Summer School on Medicines

Posted on June 27, 2017

SOM Biotech closed €2M funding round and opens €10M Series A

Posted on June 27, 2017

SOM Biotech at World Orphan Drug Congress USA 2017